Your location:Home page > Program
Jiandan QIAN
Share the:
Peking university first hospital | 感染科

The lecture video:0

Abstract:3

42

0

0

The academic assignments are as follows
Date (UTC+8) Time (UTC+8) Local Time Room Session Role Talk Title
2022-09-16 16:06-16:18 2022-09-16,16:06-16:18Meeting Room 1

Oral Presentation 2

Speaker Subcutaneous PD-L1 Antibody ASC22 (Envafolimab) plus Nucleos(t)ide Analogs Achieved Functional Cure of Chronic Hepatitis B in 42.9% of Patients with HBsAg ≤100 IU/mL: Interim Results from a Phase IIb Clinical Trial